Jeff Garro
Stock Analyst at Stephens & Co.
(0.82)
# 3,891
Out of 4,964 analysts
50
Total ratings
32.35%
Success rate
-12.72%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLP Simulations Plus | Maintains: Overweight | $28 → $20 | $14.36 | +39.28% | 2 | Jul 15, 2025 | |
| TBRG TruBridge | Reiterates: Equal-Weight | $28 | $20.12 | +39.17% | 3 | Apr 10, 2025 | |
| VEEV Veeva Systems | Reiterates: Overweight | $280 | $293.59 | -4.63% | 2 | Mar 6, 2025 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $7 → $5 | $3.69 | +35.50% | 4 | Mar 6, 2025 | |
| CERT Certara | Reiterates: Overweight | $17 | $10.99 | +54.76% | 5 | Feb 27, 2025 | |
| EVH Evolent Health | Maintains: Equal-Weight | $16 → $12 | $9.62 | +24.74% | 5 | Jan 21, 2025 | |
| PRVA Privia Health Group | Reiterates: Overweight | $26 | $21.76 | +19.51% | 3 | Jan 7, 2025 | |
| DH Definitive Healthcare | Initiates: Equal-Weight | $5 | $4.05 | +23.61% | 1 | Dec 20, 2024 | |
| DOCS Doximity | Initiates: Equal-Weight | $55 | $67.99 | -19.11% | 1 | Dec 20, 2024 | |
| OPRX OptimizeRx | Initiates: Equal-Weight | $5.5 | $17.60 | -68.75% | 3 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $250 | $188.80 | +32.42% | 2 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $16.31 | +4.23% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $31.99 | -12.47% | 8 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $7.74 | +261.76% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $16.14 | +23.92% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $4.01 | -2.62% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $2.41 | +24.48% | 3 | May 6, 2022 |
Simulations Plus
Jul 15, 2025
Maintains: Overweight
Price Target: $28 → $20
Current: $14.36
Upside: +39.28%
TruBridge
Apr 10, 2025
Reiterates: Equal-Weight
Price Target: $28
Current: $20.12
Upside: +39.17%
Veeva Systems
Mar 6, 2025
Reiterates: Overweight
Price Target: $280
Current: $293.59
Upside: -4.63%
Health Catalyst
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.69
Upside: +35.50%
Certara
Feb 27, 2025
Reiterates: Overweight
Price Target: $17
Current: $10.99
Upside: +54.76%
Evolent Health
Jan 21, 2025
Maintains: Equal-Weight
Price Target: $16 → $12
Current: $9.62
Upside: +24.74%
Privia Health Group
Jan 7, 2025
Reiterates: Overweight
Price Target: $26
Current: $21.76
Upside: +19.51%
Definitive Healthcare
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5
Current: $4.05
Upside: +23.61%
Doximity
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $67.99
Upside: -19.11%
OptimizeRx
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5.5
Current: $17.60
Upside: -68.75%
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $188.80
Upside: +32.42%
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $16.31
Upside: +4.23%
May 31, 2024
Reiterates: Overweight
Price Target: $28
Current: $31.99
Upside: -12.47%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $7.74
Upside: +261.76%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $16.14
Upside: +23.92%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $4.01
Upside: -2.62%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $2.41
Upside: +24.48%